1. Home
  2. NEWS
  3. Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.

Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.

Joe Golemme, CFO of Porosome Therapeutics, Inc., invited to participate in the J.P. Morgan 42nd Annual Healthcare Conference 2024 (January 8-11th, 2024) in San Francisco, CA, USA.
Porosome Therapeutics Announces its Patent Estate Review Results: “The strategic analysis confirmed that Porosome Therapeutics occupies a distinct and defensibleintellectual property position within the emerging field of secretion restoration technologies. Porosome Therapeutics has successfully carved out a highly defensible white space” (March 11, 2026)
From the Chairman's Desk (Feb. 23, 2026) Porosome Therapeutics Therapies
From the CEO's DESK (2026)